AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Roche’s reported $750M PathAI deal shows pathology AI moving from venture story to strategic asset
Roche’s reported acquisition of PathAI for $750 million signals how pathology AI is becoming strategically valuable to major diagnostics and life sciences companies. The deal would mark another step in the consolidation of AI assets around incumbents with distribution, data, and clinical reach.
Mobile-health Network Solutions Bets $119 Million on AI-Driven Expansion Across Asia and Africa
Mobile-health Network Solutions says it has entered a non-binding US$119 million strategic framework with Hector Capital to acquire BIMA and M&M Helix, aiming to accelerate AI-powered healthcare expansion across Asia and Africa. The deal underscores how digital health companies are using M&A and platform consolidation to chase scale in emerging markets.
Healthcare AI Is Merging Quality Data With Operations in Medisolv’s Health Elements Deal
Medisolv’s acquisition of Health Elements AI points to a growing market for tools that turn quality data into operational action. The deal reflects a shift from analytics that merely report performance to software that helps organizations act on it.
AI Imaging M&A Heats Up as Azra Buys a Rival Focused on Incidental Findings
Radiology AI vendor Azra has acquired a rival focused on incidental findings, underscoring consolidation in a crowded imaging AI market. The deal suggests vendors are increasingly chasing workflow control rather than single-use algorithms. Incidental findings are clinically important but operationally messy, making them a natural target for platforms that can connect detection, follow-up, and care coordination.
Healthcare AI Funding Surges to $7.4 Billion as Investors Double Down on Drug Discovery and M&A
Healthcare AI funding reached $7.4 billion in the first quarter of 2026, with AI drug discovery and M&A doing much of the heavy lifting. The data suggests investors are favoring platforms with clearer commercialization paths and strategic buyers are helping sustain the market.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.